Nonalcoholic Steatohepatitis in Chinese Children
Recruiting · NCT03190538 · Observational (researchers observe without assigning treatment) · Lead sponsor: Humanity and Health Research Centre
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Nonalcoholic steatohepatitis (NASH) is now recognised as an increasing clinical problem in children. Steatosis without significant liver cell injury or fibrosis is the most common form of nonalcoholic fatty liver disease (NAFLD) in both adults and children. Studies in the adult population have variably suggested that steatosis is a benign nonprogressive condition and NASH is recognised as a potentially serious condition with significantly risk of morbidity and mortality. A growing body of evidence suggests that children with NASH frequently show histopathological features that differ from those of adults. The prevalence of this pattern in a wide range of paediatric cases as well as other histopathological lesions and their relevance and prognostic significance in children with NAFLD remains to be determined. Thus the investigators would like to conduct a study of biopsies and clinical information to document the histological features of paediatric NAFLD, to explore the natural history of paediatric NAFLD, and to determine the frequency and prognostic value of these features.
Who can take part
Inclusion criteria
- age 1-18 with biopsy-proven NAFLD
- Alcohol consumption less than 20g/day and 10g/day for boys and girls respectively
Exclusion criteria
- with viral hepatitis, e.g. HBV, HCV
- with a1-anti-trypsin disease
- with autoimmune hepatitis
- with Wilson disease
- with liver impaired by drugs
Where it is running
1 location listed.
- Children's Liver Disease Center, 302 Hospital - Beijing, China